p68 RNA Helicase Inhibitors
P68 RNA helicase inhibitors are a class of chemical compounds that target a specific enzyme known as p68 RNA helicase. RNA helicases are a group of proteins that play crucial roles in the regulation of RNA molecules within cells. They are responsible for unwinding and restructuring RNA molecules, making them essential for various cellular processes, including transcription, translation, and RNA processing. P68 RNA helicase, in particular, is a member of the DEAD-box helicase family and is involved in the unwinding of RNA secondary structures, RNA-RNA interactions, and RNA-protein complexes. Inhibition of p68 RNA helicase activity can have profound effects on gene expression, RNA stability, and other RNA-related processes.
Chemical compounds classified as p68 RNA helicase inhibitors are designed to specifically interfere with the enzymatic activity of p68 RNA helicase. These inhibitors typically target the active site or binding sites of p68 RNA helicase, preventing it from unwinding RNA structures or disrupting RNA-protein interactions effectively. By inhibiting p68 RNA helicase, these compounds can modulate RNA processing and gene expression, offering insights into the fundamental mechanisms governing cellular functions. The study and development of p68 RNA helicase inhibitors have become increasingly important in the field of molecular biology and biochemistry, as they provide valuable tools for researchers to investigate the intricate processes involved in RNA metabolism and may have implications in various biological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3 | 808118-40-3 unlabeled | sc-488006 | 10 mg | $12000.00 | ||
Roxadustat may inhibit p68 by interfering with the hypoxia-inducible factor pathway, which is known to regulate the expression of various genes including those involved in cell proliferation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is a flavonoid that can modulate signal transduction pathways and potentially downregulate the expression of certain proteins implicated in cancer, possibly including p68. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol affects the expression of multiple genes through its action on sirtuins and NF-kB, which could lead to a decrease in p68 levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 may affect the PI3K/Akt signaling pathway, thus potentially decreasing the expression of proteins like p68 that are involved in cell growth and survival. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in protein synthesis regulation, which could result in reduced expression of p68 as part of a broader suppression of translation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that may indirectly downregulate p68 expression by inhibiting various signaling pathways within the cell. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 specifically inhibits MEK, which is part of the MAPK/ERK pathway, a pathway that can regulate the synthesis of various proteins, potentially including p68. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG inhibits Hsp90, which is known to stabilize many client proteins. Inhibiting Hsp90 could lead to the destabilization and decreased expression of p68. | ||||||
SN 38 | 86639-52-3 | sc-203697 sc-203697A sc-203697B | 10 mg 50 mg 500 mg | $119.00 $342.00 $883.00 | 19 | |
SN-38 is the active metabolite of irinotecan, and by inhibiting topoisomerase I, it can lead to reduced expression of proteins involved in DNA replication and cell cycle progression, including p68. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439 is an Aurora kinase inhibitor, and by disrupting mitotic processes, it could theoretically downregulate the expression of proteins like p68 that are involved in cell division. | ||||||